European Innovation Council

Plair SA develops and manufactures systems for preventive environment monitoring. It offers Rapid-E, an instrument that accurately and comprehensively analyze single aerosol particles in real time; and Rapid-C uses laser-induced fluorescence and light scattering detection, providing unprecedented high-level output in particle counts. The company was founded in 2014 and is based in Plan-les-Ouates, Switzerland.

Neurosoft Bioelectronics specializes in the development of soft implantable electrodes designed to interface with the nervous system for diagnosing and treating neurological disorders. Based in Geneva, Switzerland, the company has created next-generation electrodes that are compliant and conformable, addressing the limitations of existing stiff devices. Their flagship product, SOFT ECoG, is a subdural electrode that records from and stimulates the brain's surface, enhancing recording quality and minimizing MRI artifacts. Neurosoft's technology promotes long-term bio-integration, adapting to both static and dynamic mechanics of neural tissue, which can improve therapeutic outcomes for patients and expand the applications of neural interfaces in clinical settings.

Deasyl is identified, in-licence, and develops novel chemistry into scalable processes used by major fine chemical and petrochemical players.

EBAMed SA is a Swiss startup based in Geneva whose mission is to enable safe and effective non-invasive treatments of heart arrhythmias with protontherapy. The company is currently developing a medical device to enable non-invasive heart motion imaging and real-time synchronization of the therapeutic beam. This device consists in both hardware and software components and expands treatment possibilities for existing protontherapy centres, enabling them for the first time to treat heart patients.